| Covid-19 | Apr 20, 2020

DEA Guidance Provides Increased Flexibility on Delivery of Controlled Substances

This guidance temporarily allows DEA-registered practitioners to distribute controlled substances with fewer limitations, to meet the increasing demand as a result of the public health emergency.